Physician profile
William Ernest Winter
NPI 1124049754
$30,002.14
in general payments reported to CMS, 2019-2025
5 companies · $26K in 2025
The $26K reported for 2025 was more than what 94% of Clinical Pathology/Laboratory Medicine providers received nationally (typical 2025 total: $114).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.64 · 2022: $2,400 · 2023: $1,208 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Consulting Fee: $218 · Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,225.00 |
| Consulting Fee | $217.50 |
| Food and Beverage | $107.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bio-Rad Laboratories, INC. | $27,225.00 | 2023-2025 | Diabetes |
| Roche Diagnostics Corporation | $2,400.00 | 2022 | |
| Becton, Dickinson and Company | $217.50 | 2023 | |
| Werfen USA LLC | $107.00 | 2025 | |
| Agilent Technologies, INC. | $52.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.